Based on the Profound Medical Corp stock forecast from 1 analysts, the average analyst target price for Profound Medical Corp is CAD 16.50 over the next 12 months. Profound Medical Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Profound Medical Corp is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Profound Medical Corp’s stock price was CAD 10.61. Profound Medical Corp’s stock price has changed by -3.72% over the past week, +6.31% over the past month and -29.22% over the last year.
No recent analyst target price found for Profound Medical Corp
No recent average analyst rating found for Profound Medical Corp
Company Overview Profound Medical Corp
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada. Read Less
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead ...Read More
Frequently Asked Questions About Profound Medical Corp (PRN:CA) Stock
Based on ratings from 1 analysts Profound Medical Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 2 buy, sell and hold ratings.
Unfortunately we do not have enough data on PRN:CA's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for PRN:CA is CAD 16.50 over the next 12 months. The maximum analyst target price is CAD 16.5 while the minimum anlayst target price is CAD 16.5.
PRN:CA stock's Price/Earning ratio is 74.00.
Our analysis grades PRN:CA stock's Price / Earning ratio at F. This means that PRN:CA stock's Price/Earning ratio is above 67% of the stocks in the Medical Devices sector in the TSX exchange.
Based on this PRN:CA may be a overvalued for its sector.
The last closing price of PRN:CA's stock was CAD 10.61.
The most recent market capitalization for PRN:CA is CAD 0.26B.
Based on targets from 1 analysts, the average taret price for PRN:CA is projected at CAD 16.50 over the next 12 months.
This means that PRN:CA's stock price may go up by +55.51% over the next 12 months.
We can't find any ETFs which contains Profound Medical Corp's stock.
As per our most recent records Profound Medical Corp has 131 Employees.
Profound Medical Corp's registered address is 2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5.
You can get more information about it from Profound Medical Corp's website at https://www.profoundmedical.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Profound Medical Corp (PRN:CA) Stock
Based on ratings from 1 analysts Profound Medical Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 2 buy, sell and hold ratings.
Unfortunately we do not have enough data on PRN:CA's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for PRN:CA is CAD 16.50 over the next 12 months. The maximum analyst target price is CAD 16.5 while the minimum anlayst target price is CAD 16.5.
PRN:CA stock's Price/Earning ratio is 74.00.
Our analysis grades PRN:CA stock's Price / Earning ratio at F. This means that PRN:CA stock's Price/Earning ratio is above 67% of the stocks in the Medical Devices sector in the TSX exchange.
Based on this PRN:CA may be a overvalued for its sector.
The last closing price of PRN:CA's stock was CAD 10.61.
The most recent market capitalization for PRN:CA is CAD 0.26B.
Based on targets from 1 analysts, the average taret price for PRN:CA is projected at CAD 16.50 over the next 12 months.
This means that PRN:CA's stock price may go up by +55.51% over the next 12 months.
We can't find any ETFs which contains Profound Medical Corp's stock.
As per our most recent records Profound Medical Corp has 131 Employees.
Profound Medical Corp's registered address is 2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5.
You can get more information about it from Profound Medical Corp's website at https://www.profoundmedical.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for PRN:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
